Talking Rheumatology Research

Episode

• 
  Ep 51. Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial 14.08.2025 9mnt

  In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
• 
  Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica 12.06.2025 10mnt

  How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica? In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study. Further reading: Read Steven's full study in Rheumatology Thanks for...
• 
  Ep 49. Improving time to diagnosis in axial spondyloarthritis 08.05.2025 11mnt

  How can we improve time from symptom onset to axSpA diagnosis? In this episode, Dr Fabian Proft talks to Dr Antoni Chan about his fantastic work to reduce time to diagnosis in axial spondyloarthritis (axSpA) using an integrated referral and education system. They discuss the importance of a multi-pronged approach to education, as well as how clinicians might start improving time to axSpA diagnosis in their own settings. Further reading: Read Antoni's full article in Rheumatology A...
• 
  Ep 48. Deciphering difficult-to-treat psoriatic arthritis 24.10.2024 18mnt

  Should there be distinct definitions for difficult-to-treat and complex-to-manage psoriatic arthritis? In this episode of Talking Rheumatology Research, Dr Fabian Proft and Dr Andre Ribeiro join Dr Ai Lyn Tan to discuss their work to define difficult-to-treat psoriatic arthritis, as part of GRAPPA's wider D2T-PsA project. Find out more: Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals ...
• 
  Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis 26.08.2024 11mnt

  Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients. Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a multidisciplinary approach to managing this condition. You can read this article [https://doi.org/10.1093/rhe...
• 
  Ep 46. Patient involvement in Rheumatology research 11.07.2024 22mnt

  Peter Boyd and Ingrid de Groot join Dr. Latika Gupta to explore the value of patient involvement in Rheumatology research. Reflecting on their lived experience, Peter and Ingrid discuss their proudest moments, and identify areas in the patient and physician partnership that they hope to improve in the future. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to r...
• 
  Ep 45. Community awareness of childhood arthritis in the UK 13.06.2024 10mnt

  Recorded at #BSR24, Richard P Beesley joins Dr Ai Lyn Tan to discuss his recent article, which measured the level of community awareness in the UK that children and young people can develop arthritis. Listen now to hear about what you can do to help raise awareness of childhood arthritis, and why this is so important. You can read this article [https://doi.org/10.1093/rap/rkad099] in Rheumatology Advances in Practice. Keywords: Juvenile idiopathic arthritis, arthritis, awareness, communicatio...
• 
  Ep 44. Neuropsychiatric symptoms in systemic autoimmune rheumatic diseases 23.05.2024 13mnt

  In this fascinating episode recorded at #BSR24, Dr Melanie Sloan joins Prof Ernest Choy to discuss the latest results from the INSPIRE study, which seeks to understand neuropsychiatric symptom prevalence and impact in people with systemic autoimmune rheumatic diseases (SARDs). Dr Melanie Sloan is a researcher in the Department of Public Health and Primary Care at the University of Cambridge. Her research focuses on improving patient-clinician relationships, as well as trialling interven...
• 
  Ep 43. The metaverse: a new frontier for rheumatology 11.04.2024 12mnt

  Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients. Listen now to hear about the current technological developments and what this means for future clinical practice! You can read this article [https://doi.org/10.1093/rheumatology/kead534] in Rheumatology. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResear...
• 
  Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis? 11.01.2024 18mnt

  Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab. Listen now to hear the findings and what this means for future clinical practice! You can read this article [https://doi.org/10.1093/rheumatology/kead457] in Rheumatology. Thanks for listening to Talking Rh...
• 
  Ep 41. Addressing the leaky pipeline 04.01.2024 18mnt

  What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatology. Want to read more? Here's your further reading list: 1. Read Christina and Isabella's full paper 2. Read Latika's work on the gender gap in journal Editorial Boards Thanks for listening to Ta...
• 
  Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy 21.12.2023 5mnt

  We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's keen to see. Ernest will take the reins from Dr Marwan Bukhari (Royal Lancaster Infirmary), who finishes his highly productive term as Editor-in-Chief in February 2024. Want to discuss a potential article? Email editorial@rheumatology.org.uk. Thanks f...
• 
  Ep 39. UK JIA Biologics Register: stopping biologics for remission 30.11.2023 11mnt

  What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a consultant rheumatologist based at University College London. Managed by the University of Manchester, the UK JIA Biologics Register is a colla...
• 
  Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study 26.10.2023 8mnt

  Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDMARD-IR). Listen now to hear the findings and what this means for future clinical practice! You can read this article [https://doi.org/10.1093...
• 
  Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes? 19.10.2023 13mnt

  Anika Hoque joins Dr Michael Backhouse to discuss their recent article, which examines the construct validity of the RA foot disease activity index in relationship to musculoskeletal ultrasonography and clinical examination. Listen now to hear the findings, and what this means for future clinical practice and the impact on RA patients at risk for poor functional and radiological outcomes. You can read this article [https://doi.org/10.1093/rap/rkad048] in Rheumatology Advances in Practice. ...
• 
  Ep 36. Trainee Publishing Programme 2023: Dr Charlotte Sharp & Karen Staniland 12.10.2023 20mnt

  Can patients with rheumatoid arthritis examine their own joints? Dr David Liew talks to Dr Charlotte Sharp and Karen Staniland about their work to create a video teaching patients how to self-examine tender and swollen joints. Charlotte is now a consultant rheumatologist based in Manchester and has an interest in applied health research. Karen is the patient and public involvement lead for the REMORA project and has rheumatoid arthritis. Their paper was a winning entry to the 202...
• 
  Ep 35. Trainee Publishing Programme 2023: Dr Pallavi Shamdasani 05.10.2023 19mnt

  How can we best diagnose septic arthritis in the acute care setting? Dr Pallavi Shamdasani joins Prof Rene Westhovens to discuss the utility of synovial aspiration and intra-operative synovial fluid and tissue culture for the accurate diagnosis of septic arthritis. Dr Shamdasani is a dual trained rheumatologist and obstetric medicine physician based in Melbourne, Australia. Her paper was a winning entry to the 2023 Rheumatology Advances in Practice Trainee Publishing Programme. Read the ...
• 
  Ep 34. Trainee Publishing Programme 2023: Dr Shivani Gor & Dr Sung-Hee Kim 28.09.2023 17mnt

  What is the relationship between COVID-19 vaccination and disease flares in patients with inflammatory arthritis (IA)? Dr Shivani Gor and Dr Sung-Hee Kim join Dr Mwidimi Ndosi to discuss their retrospective study, which used C-reactive protein as a marker to determine the proportion of IA patients who had a flare within four weeks of receiving a vaccination for COVID-19. Dr Gor and Dr Kim are currently rheumatology trainees at Great Western Hospital, UK. Their paper was one of the w...
• 
  Ep 33. Trainee Publishing Programme 2023: Dr Lauren Huckerby 21.09.2023 17mnt

  What evidence is there for effective transitional care in young people with chronic pain, and what should ideal transitional care look like? Dr Lauren Huckerby joins Dr Diederik De Cock to discuss her recent systematic review - one of the winning papers from the 2023 Rheumatology Advances in Practice Trainee Publishing Programme. Dr Huckerby is a paediatric and adolescent rheumatology registrar at Royal Manchester Children’s Hospital. Read the winning paper: Growing up with chronic pain...
• 
  Ep 32. Trainee Publishing Programme 2023: Dr Cristiana Sieiro Santos 14.09.2023 12mnt

  Can we classify the clinical phenotype of systemic sclerosis by autoantibodies? Dr Cristiana Sieiro Santos joins Dr Anastasia Madenidou to discuss her recent article - one of the winning papers from the 2023 Rheumatology Advances in Practice Trainee Publishing Programme. Dr Sieiro Santos is currently a rheumatology trainee at Complejo Asistencial Universitario de León, Spain, and is working on her PhD. Read her winning paper: Clinical phenotype in scleroderma patients based on autoantib...